Back to Results
First PageMeta Content
Medicine / Nanomaterials / Anthracyclines / Doxorubicin / Alternative complement pathway / IC3b / Immunoassay / Complement component 3 / Nanoparticle / Complement system / Immunologic tests / Biology


Microsoft Word - NCL_Method_ITA-5.2_RMC edit.doc
Add to Reading List

Document Date: 2011-09-26 14:00:18

Open Document

File Size: 77,71 KB

Share Result on Facebook

Company

EMD Biosciences Inc. / IgG / Ben Vanue Laboratories Inc. / Quidel Corp. / Ortho Biotech Products LP / /

/

IndustryTerm

active pharmaceutical ingredient / individual complement split product / /

MedicalCondition

JE / stronger hypersensitivity / hypersensitivity / /

Organization

Complement Activation Nanotechnology Characterization Laboratory National Cancer Institute / /

Person

Ann Oncol / Barry W. Neun / Marina A. Dobrovolskaia / Frederick Frederick / /

/

Product

Doxil / Glycine / /

RadioStation

Muggia FM / /

Technology

2010 This protocol / antibodies / API / /

URL

http /

SocialTag